Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.55% Nasdaq Up0.29%

Regeneron Pharmaceuticals, Inc. (REGN)

288.08 1.93(0.67%) Apr 15, 4:00PM EDT
Get the big picture on all your investments.
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.2

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:344.74
Median Target:340.00
High Target:410.00
Low Target:276.00
No. of Brokers:19

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Feb 13, 2014OppenheimerDowngradeOutperformPerform
Aug 22, 2013OppenheimerInitiated Outperform
May 17, 2013UBSInitiated Neutral
Feb 28, 2013BarclaysInitiated Overweight
Jan 10, 2012Robert W. BairdUpgradeNeutralOutperform
Apr 29, 2011RBC Capital MktsDowngradeOutperformSector Perform
Apr 27, 2011Boenning & ScattergoodInitiated Outperform
Apr 7, 2011MP AdvisorsUpgradeMarket PerformOutperform
Feb 24, 2011RBC Capital MktsUpgradeSector PerformOutperform
Feb 23, 2011Stifel NicolausInitiated Hold

More Upgrades & Downgrades for REGN

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy5455

Data provided by Thomson/First Call

Currency in USD.